SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 31 filers reported holding SINOVAC BIOTECH LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,747 | 0.0% | 1,661 | 0.0% | 0.00% | – |
| Q2 2023 | $10,747 | -2.3% | 1,661 | -1.5% | 0.00% | – |
| Q3 2022 | $11,000 | -42.1% | 1,687 | -42.6% | 0.00% | – |
| Q2 2022 | $19,000 | – | 2,937 | +53.6% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 1,912 | 0.0% | 0.00% | – |
| Q3 2021 | $19,000 | – | 1,912 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1,912 | -0.5% | 0.00% | – |
| Q1 2021 | $0 | – | 1,922 | -0.1% | 0.00% | – |
| Q4 2020 | $0 | – | 1,923 | +18.6% | 0.00% | – |
| Q3 2020 | $0 | – | 1,622 | -37.6% | 0.00% | – |
| Q2 2020 | $0 | – | 2,601 | +15.5% | 0.00% | – |
| Q1 2020 | $0 | – | 2,251 | -43.9% | 0.00% | – |
| Q4 2019 | $0 | – | 4,014 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 4,014 | +0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 4,013 | +221.0% | 0.00% | – |
| Q1 2019 | $8,000 | -11.1% | 1,250 | 0.0% | 0.00% | – |
| Q4 2018 | $9,000 | -10.0% | 1,250 | 0.0% | 0.00% | – |
| Q3 2018 | $10,000 | +11.1% | 1,250 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | -18.2% | 1,250 | 0.0% | 0.00% | – |
| Q1 2018 | $11,000 | +10.0% | 1,250 | 0.0% | 0.00% | – |
| Q4 2017 | $10,000 | +11.1% | 1,250 | 0.0% | 0.00% | – |
| Q3 2017 | $9,000 | +12.5% | 1,250 | 0.0% | 0.00% | – |
| Q2 2017 | $8,000 | +14.3% | 1,250 | 0.0% | 0.00% | – |
| Q1 2017 | $7,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q4 2016 | $7,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | -22.2% | 1,250 | -10.7% | 0.00% | – |
| Q1 2016 | $9,000 | -30.8% | 1,400 | -37.4% | 0.00% | – |
| Q4 2015 | $13,000 | -27.8% | 2,237 | -37.2% | 0.00% | – |
| Q3 2015 | $18,000 | +157.1% | 3,561 | +184.9% | 0.00% | – |
| Q2 2015 | $7,000 | -86.5% | 1,250 | -88.3% | 0.00% | – |
| Q1 2015 | $52,000 | +85.7% | 10,660 | +100.0% | 0.00% | – |
| Q4 2014 | $28,000 | +16.7% | 5,330 | +10.4% | 0.00% | – |
| Q3 2014 | $24,000 | -11.1% | 4,830 | 0.0% | 0.00% | – |
| Q2 2014 | $27,000 | +440.0% | 4,830 | +544.0% | 0.00% | – |
| Q1 2014 | $5,000 | 0.0% | 750 | 0.0% | 0.00% | – |
| Q4 2013 | $5,000 | +25.0% | 750 | 0.0% | 0.00% | – |
| Q3 2013 | $4,000 | +33.3% | 750 | 0.0% | 0.00% | – |
| Q2 2013 | $3,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |